Erlotinib Induced Trichomegaly of the Eyelashes

Tuberculosis and Respiratory Diseases

article

Sang-Hoon Jeon¹  Jeong-Seon Ryu¹  Gwang-Seong Choi²  Jung-Soo Kim¹  Hea-Yoon Kwon¹  Min-Su Kim¹  Hae-Seong Nam¹  Jae-Hwa Cho¹  Seung-Min Kwak¹  Hong Lyeol Lee¹  Hyun-Jung Kim¹  Geun-Jeong Hong¹ 

[1] Department of Internal Medicine, Inha University College of Medicine, Incheon;Department of Dermatology, Inha University College of Medicine, Incheon

关键词: Receptor;    Epidermal Growth Factor;    Erlotinib;    Lung Neoplasms;    Eyelashes;    Physiological Effects of Drugs;   

DOI  :  10.4046/trd.2013.74.1.37

学科分类：医学（综合）

来源: The Korean Academy of Tuberculosis and Respiratory Diseases

【 摘 要 】

Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.

【 授权许可】

CC BY-NC